ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,610.00
      1.24%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      11/12/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20195:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20194:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Progr...NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20195:27PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20194:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019NASDAQ:ACRSAclaris Therapeutics Inc
      10/24/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Second Successful Pi...NASDAQ:ACRSAclaris Therapeutics Inc
      10/17/20196:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      10/15/20195:01PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ACRSAclaris Therapeutics Inc
      10/11/20196:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      10/10/20194:02PMGlobeNewswire Inc.Aclaris Therapeutics Announces Divestiture of RHOFADE®NASDAQ:ACRSAclaris Therapeutics Inc
      10/08/20195:01PMGlobeNewswire Inc.Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Ve...NASDAQ:ACRSAclaris Therapeutics Inc
      09/27/20197:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      09/17/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics to Hold R&D DayNASDAQ:ACRSAclaris Therapeutics Inc
      09/16/20194:15PMGlobeNewswire Inc.Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Tria...NASDAQ:ACRSAclaris Therapeutics Inc
      09/09/20197:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      09/05/20198:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      09/05/20198:30AMGlobeNewswire Inc.Aclaris Therapeutics Announces New Strategic DirectionNASDAQ:ACRSAclaris Therapeutics Inc
      08/29/20194:23PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      08/08/20195:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      08/08/20194:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      08/08/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics Reports Second Quarter 2019 Financial Results, Provides Business Strategy Update and Provides Update on ...NASDAQ:ACRSAclaris Therapeutics Inc
      08/01/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019NASDAQ:ACRSAclaris Therapeutics Inc
      07/31/20197:18AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      07/30/20194:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      07/30/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary EndpointNASDAQ:ACRSAclaris Therapeutics Inc
      07/29/20194:34PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      07/09/20195:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      07/09/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADE® (Oxymetazoline Hydrochlo...NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS